Zobrazeno 1 - 10
of 251
pro vyhledávání: '"Norio, Asou"'
Autor:
Yuriko Nishiyama-Fujita, Tomonori Nakazato, Noriyoshi Iriyama, Michihide Tokuhira, Maho Ishikawa, Eriko Sato, Tomoiku Takaku, Keiji Sugimoto, Hiroyuki Fujita, Isao Fujioka, Shun Tsuchiya, Yuta Kimura, Eisaku Iwanaga, Norio Komatsu, Norio Asou, Masahiro Kizaki, Yoshihiro Hatta, Tatsuya Kawaguchi
Publikováno v:
Annals of Medicine, Vol 54, Iss 1, Pp 1244-1254 (2022)
Introduction Few studies have reported the outcomes of adolescents and young adults (AYAs) with chronic-phase chronic myeloid leukaemia (CML-CP) on tyrosine kinase inhibitors (TKIs).Materials and methods We retrospectively analysed the clinical featu
Externí odkaz:
https://doaj.org/article/2e6495f34fd84e83afef69bd99b33b59
Autor:
Yuichi Ishikawa, Naomi Kawashima, Yoshiko Atsuta, Isamu Sugiura, Masashi Sawa, Nobuaki Dobashi, Hisayuki Yokoyama, Noriko Doki, Akihiro Tomita, Toru Kiguchi, Shiro Koh, Heiwa Kanamori, Noriyoshi Iriyama, Akio Kohno, Yukiyoshi Moriuchi, Noboru Asada, Daiki Hirano, Kazuto Togitani, Toru Sakura, Maki Hagihara, Tatsuki Tomikawa, Yasuhisa Yokoyama, Norio Asou, Shigeki Ohtake, Itaru Matsumura, Yasushi Miyazaki, Tomoki Naoe, Hitoshi Kiyoi
Publikováno v:
Blood Advances, Vol 4, Iss 1, Pp 66-75 (2020)
Abstract: The prognostic impact of KIT mutation on core-binding factor acute myeloid leukemia (CBF-AML) remains controversial. We registered 199 newly diagnosed de novo CBF-AML patients, aged 16 to 64 years, who achieved complete remission. They rece
Externí odkaz:
https://doaj.org/article/d8f98219f90f425d95e4fd4f64876f2b
Autor:
Sho Kubota, Kenji Tokunaga, Tomohiro Umezu, Takako Yokomizo-Nakano, Yuqi Sun, Motohiko Oshima, Kar Tong Tan, Henry Yang, Akinori Kanai, Eisaku Iwanaga, Norio Asou, Takahiro Maeda, Naomi Nakagata, Atsushi Iwama, Kazuma Ohyashiki, Motomi Osato, Goro Sashida
Publikováno v:
Nature Communications, Vol 10, Iss 1, Pp 1-16 (2019)
Translocation of (6;8)(p21;q24), a recurrent abnormality of blastic plasmacytoid dendritic cell neoplasm, involves adjacent MYC and RUNX2 regions. Here, the authors show that the RUNX2 super-enhancer is hijacked to activate MYC in addition to RUNX2 e
Externí odkaz:
https://doaj.org/article/b55f6237adba4583b97db796afe3c64f
Autor:
Tomoya Maeda, Akira Matsuda, Chie Asou, Daisuke Okamura, Ken Tanae, Mika Kohri, Maho Ishikawa, Naoki Takahashi, Kunihiro Tsukasaki, Nobutaka Kawai, Norio Asou, Masami Bessho
Publikováno v:
Leukemia Research Reports, Vol 15, Iss , Pp 100231- (2021)
To determine the impact of peripheral blood (PB) Wilms’ tumour 1 (WT-1) mRNA levels in patients with primary myelodysplastic syndromes (MDS), we analysed the relationships between several clinical variables at the time of diagnosis and the haematol
Externí odkaz:
https://doaj.org/article/f91fb527f32840b09f7f919945b749a1
Autor:
Shun Tsuchiya, Tomoiku Takaku, Naoki Watanabe, Noriyoshi Iriyama, Yuta Kimura, Eisaku Iwanaga, Kei-ji Sugimoto, Toru Mitsumori, Maho Ishikawa, Tomonori Nakazato, Hiroyuki Fujita, Eriko Sato, Yoshihiro Hatta, Norio Asou, Masahiro Kizaki, Michihide Tokuhira, Miki Ando, Tatsuya Kawaguchi
Publikováno v:
Internal Medicine; 2023, Vol. 62 Issue 22, p3299-3303, 5p
Autor:
Maho Ishikawa, Akira Matsuda, Daisuke Okamura, Tomoya Maeda, Nobutaka Kawai, Norio Asou, Masami Bessho
Publikováno v:
Hematology Reports, Vol 10, Iss 3 (2018)
Thrombopoietin (TPO) is a critical regulator of hematopoiesis. We previously reported that a severe aplastic anemia (SAA) who received a short-term administration of pegylated recombinant human megakaryocyte growth and development factor (rHuMGDF). A
Externí odkaz:
https://doaj.org/article/4cba731d4cf14a0493be734b2333b100
Autor:
Qi Jiang, Kenichi Ishizawa, Satoru Takada, Wellington Luiz Mendes, Toshihiro Miyamoto, Takahiro Yamauchi, Nobuaki Dobashi, M. Kurokawa, Junya Kuroda, Chikashi Yoshida, Sumiko Okubo, Kensuke Usuki, Itaru Matsumura, Norio Komatsu, Andrew H. Wei, Hideyuki Honda, Norio Asou, Hiroatsu Iida, Satoshi Ichikawa, Yasushi Miyazaki
Publikováno v:
Japanese Journal of Clinical Oncology
Background In a multinational phase 3 trial (VIALE-C), venetoclax plus low-dose cytarabine prolonged overall survival vs placebo plus low-dose cytarabine in patients with newly diagnosed acute myeloid leukaemia ineligible for intensive chemotherapy,
Autor:
Chelsia Qiuxia Wang, Motomi Osato, Sayed Hamada Madboly, Norio Asou, Kimi Araki, Eisaku Iwanaga, Masao Matsuoka, Naomi Nakagata, Takako Ideue, Kenji Tokunaga, Tomomasa Yokomizo, Mariko Morii, Vania Swee Imm Teoh, Abdellah Abosrie Ali Omar, Takako Yokomizo, Goro Sashida, Akiko Niibori-Nambu, Mohamed Gaber Abdallah, Sho Kubota, Mabrouk Mahmoud Aboelenin, Michelle Meng Huang Mok
Publikováno v:
Leukemia
Autor:
Daisuke Okamura, Akira Matsuda, Maho Ishikawa, Tomoya Maeda, Ken Tanae, Mika Kohri, Naoki Takahashi, Nobutaka Kawai, Norio Asou, Masami Bessho
Publikováno v:
Leukemia Research Reports, Vol 3, Iss 1, Pp 24-27 (2014)
Myelodysplastic syndromes with myelofibrosis (MDS-F) is a poor prognostic hematopoietic disorder. Azacitidine was shown to prolong survival of high-risk MDS patients. However, the effects of azacitidine on MDS-F have yet to be elucidated. Azacitidine
Externí odkaz:
https://doaj.org/article/9b03b2fea13d445d9eb91ab8e6492c68
Autor:
Sho Kubota, Kenji Tokunaga, Tomohiro Umezu, Takako Yokomizo-Nakano, Yuqi Sun, Motohiko Oshima, Kar Tong Tan, Henry Yang, Akinori Kanai, Eisaku Iwanaga, Norio Asou, Takahiro Maeda, Naomi Nakagata, Atsushi Iwama, Kazuma Ohyashiki, Motomi Osato, Goro Sashida
Publikováno v:
Nature Communications, Vol 10, Iss 1, Pp 1-1 (2019)
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Externí odkaz:
https://doaj.org/article/a9f5b6ded55344b394d22695b04a566d